US$ 25.06
retatrutide triple agonist glp-1 gip glucagon Explained: How the Actually Works Structural insights into the triple
Description
According to FutureMarketInsights, the GLP-1 nutritional support market is forecast to reach USD 13 billion by 2035 , up from USD 4.1 billion in 2025 , advancing at a 12.2% CAGR

The approval represents Tevimbras first in the U.S

Cancers 16 , 2377 (2024)

J Cell Sci (2008) 121(Pt 9):136372
